Bio

Bob Crants is a Founding Partner and Chief Investment Officer of Pharos Capital Group. Mr. Crants is responsible for setting the firm’s investment and risk management strategy, developing targeted investment themes, supervising the transaction structuring process and fundraising. Mr. Crants is a member of the investment committees of Pharos’ funds and currently serves on the boards of Sona Dermatology and Medspa, Employee Benefit Solutions, FasPsych, MOTION Physical Therapy, TechLab, Seaside Healthcare, TotalTrax, and Verdi Oncology. Mr. Crants has been directly involved in private equity investments for over twenty-five years. Prior to founding Pharos, Mr. Crants was with Goldman Sachs, where he was a founding member of the Special Investments Group, and was active in the development and marketing of proprietary equity derivative products, equity private placements, exchange funds and merchant banking funds totaling over $6.0 billion in gross funds raised. As a result of his work, in 1993 he received the Goldman Sachs Investment Banking Division Innovation Award. From 1997 through 2000, Mr. Crants was the President and on the Board of Trustees of Prison Realty Trust, a New York Stock Exchange traded Real Estate Investment Trust (REIT). Mr. Crants graduated from Princeton University with an A.B., summa cum laude, in Economics. Mr. Crants is based out of the firm's Nashville office.